Skip to main content
. 2019 Mar 17;9(3):449. doi: 10.3390/nano9030449

Figure 14.

Figure 14

(A) T2 weight images after intravenous and intra-arterial administration of 1.4 mg/kg of HMMSN hybrid magnetic mesoporous nanorods. (B,C) GOT and GPT levels normalized to baseline at different time points after intravenous and intra-arterial administrations, respectively. (N = 3/group).